Neurocrine Biosciences
Clinical trials sponsored by Neurocrine Biosciences, explained in plain language.
-
New hope for cerebral palsy movement issues: drug trial shows promise
Symptom relief CompletedThis study tested a drug called valbenazine to see if it can reduce jerky, uncontrolled movements (chorea) in children and adults with cerebral palsy. 86 participants received either the drug or a placebo for 14 weeks. The goal was to measure changes in movement severity using st…
Phase: PHASE3 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated May 22, 2026 13:51 UTC
-
New hope for uncontrollable movements: valbenazine shows promise in TD study
Symptom relief CompletedThis study looked at how well valbenazine works for tardive dyskinesia (TD), a condition causing uncontrollable movements often linked to long-term use of certain mental health medications. Fifty-nine adults with schizophrenia, bipolar disorder, or major depression took valbenazi…
Phase: PHASE4 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated May 19, 2026 11:47 UTC
-
New depression drug shows promise in early trial
Symptom relief CompletedThis study tested an experimental drug called NBI-1070770 in 73 adults with major depressive disorder. The goal was to see if it could safely and quickly improve depression symptoms compared to a placebo. Participants continued their usual antidepressants during the trial.
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC